Shares of HIMS experienced a dramatic drop today following the unexpected termination of its partnership with pharmaceutical giant Novo Nordisk. Investors reacted negatively to the news, sending its stock price plummeting by more than fifteen percent. The reason for the dissolution of the partnership remains unclear, but industry analysts speculate